A Bayesian analysis of institutional effects in a multicenter cancer clinical trial
Related Experiment Videos
1Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.
Abstract:
This paper examines a Bayesian method for investigating the amount of institutional variation in a multicenter clinical trial with a censored failure time endpoint. A hierarchical structure is used to model the institutional effects in a proportional hazards model, with the posterior distributions calculated using Gibbs sampling. The methods are applied to data from a lung cancer trial conducted by the Eastern Cooperative Oncology Group. In this trial there appears to be substantial variation in the treatment effect across institutions. Although the reasons for this have been identified, it would be possible to investigate this further through a detailed examination of the data from institutions with extreme effects.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Bias in Epidemiological Studies
Comparing the Survival Analysis of Two or More Groups
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Confounding in Epidemiological Studies